BioLife Solutions (BLFS) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.38 +0.37%
Revenue Growth %: +3.3%
Financial Fact:
General and administrative: 1.04M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.3%
Financial Fact:
General and administrative: 1.04M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.01 million.
BioLife Solutions reaffirmed FY2016 guidance.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- CBRE Global Real Estate Income Fund adjusts September distribution after split
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
